Marker Therapeutics, Inc. (MRKR) › Weighted Average Diluted SharesMarker Therapeutics, Inc. (MRKR) — Weighted Average Diluted SharesAnnual figures by period end, from SEC filings.2015-12-31: 3.66M2016-12-31: 7.42M2017-12-31: 9.45M2020-12-31: 47.04M2021-12-31: 7.65M2022-12-31: 8.35M2023-12-31: 8.81M2024-12-31: 8.98M2025-12-31: 15.31M15.31M2015-12-31Weighted Average Diluted Shares (shares)2025-12-31Period endedWeighted Average Diluted SharesChange YoYSource filing2025-12-3115.31M+70.5%2026-03-18From 2025-01-012024-12-318.98M+1.9%2026-03-18From 2024-01-012023-12-318.81M+5.5%2025-03-31From 2023-01-012022-12-318.35M+9.2%2024-03-26From 2022-01-012021-12-317.65M-83.7%2023-03-22From 2021-01-012020-12-3147.04M—2022-03-17From 2020-01-012017-12-319.45M+27.4%2018-03-23From 2017-01-012016-12-317.42M+102.6%2018-03-23From 2016-01-012015-12-313.66M—2017-03-14From 2015-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareEPS (Basic)